Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The START Hope Hub is a digital platform designed to attach sufferers, caregivers, physicians, and advocacy teams to early-phase most cancers trials.The START...
Tripp Razor discusses the pancreatic most cancers burden in Black communities and the obstacles that contribute to poor outcomes.Though Black People face a...
